Atypical Femoral Fractures due to long-term bisphosphonates therapy

1. Med AJ. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993; 94:646-50.10.1016/0002-9343(93)90218-ESearch in Google Scholar

2. Nieves JW, Cosman F. Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates. Curr Osteoporos Rep. 2010; 8:34–39.10.1007/s11914-010-0007-220425089Search in Google Scholar

3. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008; 22:346–350.10.1097/BOT.0b013e318172841c18448990Open DOISearch in Google Scholar

4. Bone HG, Schurr W. Intravenous bisphosphonate therapy for osteoporosis: where do we stand?. Curr Osteoporos Rep. 2004; 2:24–30.10.1007/s11914-004-0011-516036079Search in Google Scholar

5. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005; 90:1294-301.10.1210/jc.2004-095215598694Search in Google Scholar

6. Higgins M, Morgan-John S, Badhe S. Simultaneous, bilateral, complete atypical femoral fractures after longterm alendronate use. Journal of Orthopaedics. 2016; 13:401-403.10.1016/j.jor.2016.07.007499065927570414Search in Google Scholar

7. Shane E, Burr D, Ebeling PR et al. Atypical subtrohanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010; 25:2267-94.10.1002/jbmr.25320842676Open DOISearch in Google Scholar

8. Dell R, Greene D, Ott S et al. A Retrospective Analysis of all Atypical Femur Fractures Seen in a Large California HMO from the Years 2007 to 2009. J Bone Miner Res. 2010; (Suppl 1):1201.Search in Google Scholar

9. Schilcher J, Michaelsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011; 364:1728–37.10.1056/NEJMoa101065021542743Search in Google Scholar

10. Yamagami Y, Mashiba T, Iwata K et al. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys. Bone. 2013; 54:1-7.10.1016/j.bone.2013.01.01623356990Search in Google Scholar

11. Allen MR, Burr DB. Changes in vertebral strengh-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs. Osteoporos Int. 2008; 19:95-99.10.1007/s00198-007-0451-817710353Search in Google Scholar

12. Lee KJ, Yoo JJ, Oh KJ et al. Surgical outcome of intramedullary nailing in patients with complete atypical femoral fractures: a multicenter retrospective study. Injury, Int J Care Injured. 2017; 48:941-945.10.1016/j.injury.2017.02.03628274470Open DOISearch in Google Scholar

13. Teo BJ, Koh JS, Goh SK et al. Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonates therapy. Bone Joint J. 2014; 96-b(5):658-664.10.1302/0301-620X.96B5.3288724788502Search in Google Scholar